By API User
The Aboriginal Medical Services Alliance Northern Territory (AMSANT) and Sunrise Health Service Aboriginal Corporation are celebrating a major milestone for the Big Rivers Region, with the first cohort of trainee Aboriginal health practitioners commencing training through Dijan Training. Ten trainees from across the region have enrolled in the Cert IV in Aboriginal and/or Torres Strait … Continued
By API User
Key Facts: Over 433,300 Australians live with dementia, with death rates from the condition rising annually Pressalit launches DTS™ toilet seat range in Australia, specifically designed for people with dementia The range features dementia-friendly design elements including matte finish, high colour contrast and soft-close functionality Available in black, grey and blue, the seats are compatible … Continued
By API User
Key Facts: Cardiovascular disease causes 1 in 4 deaths in Australia, with 57,000 heart attacks annually and 19 deaths per day Over 32,000 Australians experience sudden cardiac arrest yearly, with only 10% surviving without immediate intervention Survival rates can increase to 60-70% when bystanders perform immediate CPR and use an AED quickly Key first aid … Continued
By API User
The Australian College of Nursing Foundation today announced the 22 recipients of the 2026 Bullwinkel Scholars Program, honouring the enduring legacy of the nurses lost in the Bangka Island Massacre on 16 February 1942, and the sole survivor, Lieutenant Colonel Vivian Bullwinkel AO MBE ARRC ED FNM FRCNA. The Bullwinkel Scholars Program is a … Continued
By API User
Scientists have made a breakthrough toward a genetic test that could help thousands of mothers with epilepsy safely take life-saving medication without fear of it causing birth defects in their children. Valproic acid (VPA) is an anti-seizure medication, and for many people with epilepsy it is the only or most effective treatment. But several countries … Continued
By API User
MEDIA RELEASE Monday, 16 February 2026: Australia’s response to heart valve disease is moving dangerously slowly, putting hundreds of thousands of lives at risk. To help change that, leading heart charity, Hearts4heart is launching the nation’s first ‘SLOW Symptoms’ campaign during Heart Valve Disease Awareness Week (16–22 February 2026). In 2021, an estimated 600,000 Australians … Continued
By API User
Melbourne, 16 February 2026 CSL Seqirus, part of leading Australian biotechnology company CSL, has today announced that neffy® adrenaline (epinephrine) nasal spray is now available and has been approved for use in Australia for the emergency treatment of anaphylaxis in adults and children 15kg+ and aged four years and over.1 Anaphylaxis occurs after exposure to … Continued
By API User
ALYFTREK® is now reimbursed for Australians with cystic fibrosis (CF) aged 6 years and older with at least one responsive mutation – Approximately 3,200 Australians living with CF are now able to access this next-in-class treatment[i] – SYDNEY, Sunday 15th February 2026 – Vertex Pharmaceuticals today announced that as of 1 February 2026, ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor) … Continued
By API User
Blood cancer is the most commonly diagnosed childhood cancer in Australia[i] – and its growing impact is robbing far too many young Australians of the normal childhood they deserve. Leukaemia and lymphoma together account for almost half of all cancers diagnosed in those under the age of 19[ii], making blood cancer the single greatest cancer … Continued
By API User
SHANGHAI–BUSINESS WIRE– His Highness Sheikh Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, visited the Huawei Research and Development Centre and Shanghai Media Group (SMG) in Shanghai, People’s Republic of China. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260213682693/en/ Sultan bin Ahmed … Continued
